New knowledge in the physiology of hormonal contraceptives

Henzl, 1986, Contraceptive hormones and their clinical use, 643 Stanczyk, 1989, Pharmacokinetics of progestogens, 1, 11 Stanczyk, 1990, Metabolism of levonorgestrel, norethindrone and structurally related contraceptive steroids, Contraception, 42, 67, 10.1016/0010-7824(90)90093-B Fotherby, 1990, Potency and pharmacokinetics of gestogens, Contraception, 41, 533, 10.1016/0010-7824(90)90062-Z Stanczyk, 1993, Structure-function relationships, potency and pharmacokinetics of progestogens, 69 Edgren, 1976, Potencies of oral contraceptives, Am J Orsili Gynecol, 125, 1029, 10.1016/0002-9378(76)90804-8 Edgren, 1979, Relative potencies of oral contraceptives, 1 Edgren, 1980, Progestogens, 1 Skouby, 1976, The influence of the pituitary-ovarian function, cervical mucus and vaginal cytology of a new progestational compound, Contraception, 14, 529, 10.1016/0010-7824(76)90004-4 Orme, 1983, Clinical pharmacokinetics of oral contraceptive steroids, Clin Pharmacoki- net, 8, 95, 10.2165/00003088-198308020-00001 Jung-Hoffmann, 1989, Interaction with the pharmacokinetics of ethinyl estradiol and progestogens contained in oral contraceptives, Contraception, 40, 299, 10.1016/0010-7824(89)90094-2 Mashchak, 1982, Lobo Ra, Dozono-Takano R, et al, Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstfi Gynecol, 144, 511 Duffy, 1993 Mishell, 1977, The effect of contraceptive steroids on hypothalamic-pituitary function, Am J Obstet Gynecol, 129, 60, 10.1016/0002-9378(77)90295-2 Scott, 1978, Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids, Am J Obstet Gynecol, 130, 817, 10.1016/0002-9378(78)90015-7 Levin, 1989 Ortiz, 1977, Stanczyk FZt et al, Serum medroxyprogesterone acetate concentrations and ovarian function following intramuscular injection of depot-medroxyprogesterone acetate. J Clin Endocrinol Metab, 4, 32 Laurikka-Routti, 1992, Suppression of ovarian function with the transdermal^ given synthetic progestin ST-1435, Fertil Steril, 58, 680, 10.1016/S0015-0282(16)55311-4 Ditkoff, 1991, ITie gonad- otropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women, Am J Obstet Gynecol, 165, 1811, 10.1016/0002-9378(91)90037-R Shoupe, 1987, Effects of antiprogesterone RU486 in normal women. II: administration in the late follicular phase, Am J Obstet Gynecol, 157, 1421, 10.1016/S0002-9378(87)80236-3